FROM PUBLIC EVENTS · 2026-11-18

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Early clinical · first deals Has Phase 1 results for its dementia injection and keeps signing platform co-development and evaluation deals with drugmakers in Korea and abroad.

  • Announced results of the GB-5001 Phase 1 multiple-dose study. Source
  • Signed a platform evaluation contract with China's UBT. Source

Roles often seen at this stageResearch & development · Clinical & PV · Manufacturing & MSAT

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-18

G2GBIO

An Osong-based company developing improved drugs with InnoLAMP, its platform for long-acting injectables whose effect lasts long after a single shot.

GB-5001

Phase 1

Once-monthly donepezil injection for dementia; in the Phase 1 multiple-dose study, 140 mg every four weeks reached steady state within three to four doses.

InnoLAMP

Technology platform

Long-acting injectable platform; under an evaluation contract it is being applied to candidates provided by China's UBT.

Completion reported

Signed a long-acting injectable platform evaluation contract with China's UBT.

Completion reported

Announced safety and tolerability results from the GB-5001 Phase 1 multiple-dose study.

Completion reported

Signed a three-way agreement with Samsung Bioepis and Epis NexLab to develop a long-acting obesity treatment.

Official role guide

G2GBIO careers

Current availability unconfirmed

Observed 2026-11-18

Work
Unconfirmed — The official careers page was found, but postings and duties were not read in this check.
Experience & requirements
Unconfirmed — Requirements were not checked on the official careers page.

Information from a role guide does not establish a current vacancy.

Sources & coverage 3

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. GB-5001 임상 1상 다회 투여 안전성·내약성 확인 ↗지투지바이오 · Published 2026-08-27 · Sources checked 2026-11-18 · Original unavailable
  2. 지투지바이오, 中 UBT와 약효 지속성 주사제 플랫폼 평가 계약 ↗머니투데이 · Published 2026-10-19 · Sources checked 2026-11-18 · Original unavailable
  3. 채용안내 ↗지투지바이오 · Published Date unconfirmed · Sources checked 2026-11-18 · Original unavailable